105 related articles for article (PubMed ID: 22616589)
1. The feasibility of an early hospital discharge following chemotherapy for the acute myeloid leukemia.
Sopko L; Sabty FA; Rimajova V; Roziakova L; Elanova A; Demeckova E; Mistrik M
Bratisl Lek Listy; 2012; 113(5):298-300. PubMed ID: 22616589
[TBL] [Abstract][Full Text] [Related]
2. Selective discharge of patients with acute myeloid leukemia during chemotherapy-induced neutropenia.
Gillis S; Dann EJ; Rund D
Am J Hematol; 1996 Jan; 51(1):26-31. PubMed ID: 8571934
[TBL] [Abstract][Full Text] [Related]
3. Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit.
Girmenia C; Alimena G; Latagliata R; Morano SG; Celesti F; Coppola L; Spadea A; Tosti S; Mecarocci S; D'Elia GM; Tafuri A; Cimino G; Mandelli F
Haematologica; 1999 Sep; 84(9):814-9. PubMed ID: 10477455
[TBL] [Abstract][Full Text] [Related]
4. Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.
Vaughn JE; Othus M; Powell MA; Gardner KM; Rizzuto DL; Hendrie PC; Becker PS; Pottinger PS; Estey EH; Walter RB
JAMA Oncol; 2015 Nov; 1(8):1120-7. PubMed ID: 26355382
[TBL] [Abstract][Full Text] [Related]
5. Outpatient supportive care following chemotherapy for acute myeloblastic leukemia.
Allan DS; Buckstein R; Imrie KR
Leuk Lymphoma; 2001 Jul; 42(3):339-46. PubMed ID: 11699398
[TBL] [Abstract][Full Text] [Related]
6. Outpatient management of acute promyelocytic leukemia after consolidation chemotherapy.
Girmenia C; Latagliata R; Tosti S; Morano SG; Celesti F; Coppola L; Spadea A; Breccia M; Battistini R; Tafuri A; Cimino G; Mandelli F; Alimena G
Leukemia; 1999 Apr; 13(4):514-7. PubMed ID: 10214855
[TBL] [Abstract][Full Text] [Related]
7. A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia.
Getz KD; Miller TP; Seif AE; Li Y; Huang YS; Bagatell R; Fisher BT; Aplenc R
Cancer Med; 2015 Sep; 4(9):1356-64. PubMed ID: 26105201
[TBL] [Abstract][Full Text] [Related]
8. Infectious disease management of adult leukemic patients undergoing chemotherapy: 1982 to 1986 experience at Stanford University Hospital.
O'Hanley P; Easaw J; Rugo H; Easaw S
Am J Med; 1989 Dec; 87(6):605-13. PubMed ID: 2589395
[TBL] [Abstract][Full Text] [Related]
9. Outpatient management of acute myeloid leukemia after intensive consolidation chemotherapy is feasible and reduces hospital treatment costs.
Eisele L; Günther F; Ebeling P; Nabring J; Dührsen U; Dürig J
Onkologie; 2010; 33(12):658-64. PubMed ID: 21124036
[TBL] [Abstract][Full Text] [Related]
10. A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology Group.
Miller TP; Getz KD; Kavcic M; Li Y; Huang YS; Sung L; Alonzo TA; Gerbing R; Daves M; Horton TM; Pulsipher MA; Pollard J; Bagatell R; Seif AE; Fisher BT; Gamis AS; Aplenc R
Leuk Lymphoma; 2016 Jul; 57(7):1567-74. PubMed ID: 26727639
[TBL] [Abstract][Full Text] [Related]
11. Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions.
Lee SSF; Fulford AE; Quinn MA; Seabrook J; Rajakumar I
Support Care Cancer; 2018 May; 26(5):1499-1504. PubMed ID: 29170868
[TBL] [Abstract][Full Text] [Related]
12. Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient.
Mullen CA; Buchanan GR
J Clin Oncol; 1990 Dec; 8(12):1998-2004. PubMed ID: 2230891
[TBL] [Abstract][Full Text] [Related]
13. [Reconsideration of the admission and discharge criteria of tuberculosis patients in Japan].
Masuyama H; Igari H
Kekkaku; 2013 Mar; 88(3):373-85. PubMed ID: 23672177
[TBL] [Abstract][Full Text] [Related]
14. Neutropenia-associated outcomes in adults with acute myeloid leukemia receiving cytarabine consolidation chemotherapy with or without granulocyte colony-stimulating factor.
Bradley AM; Deal AM; Buie LW; van Deventer H
Pharmacotherapy; 2012 Dec; 32(12):1070-7. PubMed ID: 23208834
[TBL] [Abstract][Full Text] [Related]
15. Health economic impact of high-dose versus standard-dose cytarabine induction chemotherapy for acute myeloid leukaemia.
Fedele PL; Avery S; Patil S; Spencer A; Haas M; Wei A
Intern Med J; 2014 Aug; 44(8):757-63. PubMed ID: 24863325
[TBL] [Abstract][Full Text] [Related]
16. Outpatient supportive care for pediatric acute myeloid leukemia: a single institution's experience.
Potashner R; Weinblatt ME; Glasser CL
Pediatr Hematol Oncol; 2021 Nov; 38(8):722-730. PubMed ID: 33792501
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemia.
Saini L; Minden MD; Schuh AC; Yee KW; Schimmer AD; Gupta V; Atenafu EG; Murray C; Nixon S; Brandwein JM
Am J Hematol; 2012 Mar; 87(3):323-6. PubMed ID: 22213349
[TBL] [Abstract][Full Text] [Related]
18. Outcome of an elective readmission policy in patients receiving acute myeloid leukaemia consolidation therapy and implications for an outpatient management programme.
Grigg A; Prabahran A; Donati V; Wong E; Mason K
Intern Med J; 2023 Aug; 53(8):1492-1496. PubMed ID: 37599226
[TBL] [Abstract][Full Text] [Related]
19. Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy.
Heng SC; Slavin MA; Al-Badriyeh D; Kirsa S; Seymour JF; Grigg A; Thursky K; Bajel A; Nation RL; Kong DC
J Antimicrob Chemother; 2013 Jul; 68(7):1669-78. PubMed ID: 23485723
[TBL] [Abstract][Full Text] [Related]
20. Results of program acute myeloid leukemia therapy use in National Medical Research Center for Hematology of the Ministry of Health of Russian Federation.
Parovichnikova EN; Loukianova IA; Troitskaya VV; Drokov MY; Lobaova TI; Kuzmina LA; Sokolov AN; Kokhno AV; Fidarova ZT; Baskhaeva GA; Gavrilina OA; Vasilyeva VA; Obukhova TN; Kuznetsova SA; Sudarikov AB; Dvirnik VN; Galtseva IV; Davidiva JO; Kulikov SM; Savchenko VG
Ter Arkh; 2018 Aug; 90(7):14-22. PubMed ID: 30701918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
